UW Medicine starts Novavax COVID-19 vaccine clinical trial

Getty Images
These trials aim to evaluate the vaccine candidate for safety and effectiveness.

UW Medicine investigators are starting volunteer enrollment for an investigational COVID-19 vaccine clinical trial. The Phase III study will examine whether the Novavax vaccine candidate can protect against SARS-CoV-2, the coronavirus responsible for COVID-19.

UW Medicine's site for enrolling participants is the Virology Research Clinic at Harborview Medical Center's Ninth and Jefferson Building. The site will enroll up to 1,000 volunteers. Investigators will make the trial accessible and equitable for populations disproportionately impacted by the COVID-19 pandemic; this would entail deploying mobile sites in other parts of the state.

Volunteers 18 and older can enroll with the Virology Research Clinic in several ways:

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.